USANA Health Sciences Reports Results for Third Quarter 2018; Updates 2018 Outlook; Board Increases Share Repurchase Authorization

Go back to USANA Health Sciences Reports Results for Third Quarter 2018; Updates 2018 Outlook; Board Increases Share Repurchase Authorization

USANA Health Sciences (USNA) Tops Q3 EPS by 12c; Raises Outlook

October 23, 2018 4:19 PM EDT

USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $1.24, $0.12 better than the analyst estimate of $1.12. Revenue for the quarter came in at $296.8 million versus the consensus estimate of $291.73 million.

GUIDANCE:

USANA Health Sciences sees Q4 2018 EPS of $5.00-$5.15, versus... More